Vivos Therapeutics: director Lindsay Mark F. received 12,000 shares

What happened

• Lindsay Mark F., a director of Vivos Therapeutics, received a grant of 12,000 stock options on Sep 14, 2026. The filing lists a price of $0.00 and a total value of $0 (derivative).

Key details

• Transaction date: Sep 14, 2026; filing date: Oct 26, 2026.
• Grant: 12,000 stock options at $0.00 (transaction code A, derivative).
• Vesting schedule: 6,000 options vested immediately; 3,000 options vest on Sep 30, 2026; 3,000 options vest on Dec 31, 2026.
• Exercise term: options are exercisable for 10 years from the Grant Date (Sep 14, 2026).
• Footnote: reflects expiry of 667 options on Jun 19, 2025 and 1,200 options on Aug 5, 2026 that expired unexercised.
• Shares owned after the transaction: not stated in the filing.

Why it may matter

• This filing reports a grant of options, not an exercise or a market sale.
• A filing does not show why the insider traded or why the company acted.